Present and future treatment strategies for coronavirus disease 2019

Present and future treatment strategies for coronavirus disease 2019

Abstract Background The recent pandemic of coronavirus disease 2019 (COVID-19) has resulted in many challenges to the healthcare organizations around the world. Unfortunately, until now, there are no proven effective therapeutic agents against this virus. Main body Several evolving studies suggest r...

Full description

Bibliographic Details
Main Authors:	Engy Elekhnawy, Amal Abo Kamar, Fatma Sonbol
Format:	Article
Language:	English
Published:	SpringerOpen 2021-04-01
Series:	Future Journal of Pharmaceutical Sciences
Subjects:	COVID-19 SARS-Cov-2 Cytokine storm Respiratory distress syndrome
Online Access:	https://doi.org/10.1186/s43094-021-00238-y

Similar Items

Coronavirus disease 2019 (COVID-19): cytokine storms, hyper-inflammatory phenotypes, and acute respiratory distress syndrome
by: Shi-hui Lin, et al.
Published: (2020-12-01)

Therapeutic potential of mesenchymal stem cells and their exosomes in severe novel coronavirus disease 2019 (COVID-19) cases
by: Atsunori Tsuchiya, et al.
Published: (2020-06-01)

Fluvoxamine: A Review of Its Mechanism of Action and Its Role in COVID-19
by: Vikas P. Sukhatme, et al.
Published: (2021-04-01)

Judicious use of low-dosage corticosteroids for non-severe COVID-19: A case report
by: Zhang Jian, et al.
Published: (2021-03-01)

Use of Cannabinoids to Treat Acute Respiratory Distress Syndrome and Cytokine Storm Associated with Coronavirus Disease-2019
by: Prakash Nagarkatti, et al.
Published: (2020-11-01)

Cytokine Signature Induced by SARS-CoV-2 Spike Protein in a Mouse Model
by: Tingxuan Gu, et al.
Published: (2021-01-01)

Perspectives on Repurposed Drugs Based on Globally Accepted Therapeutic Guidelines to Combat SARS-CoV-2 Infection
by: Rosalia R
Published: (2021-01-01)

Immune system response during viral Infections: Immunomodulators, cytokine storm (CS) and Immunotherapeutics in COVID-19
by: Faheem Hyder Pottoo, et al.
Published: (2021-02-01)

Extracorporeal Hemoperfusion as a Potential Therapeutic Option for Severe COVID-19 patients; a Narrative Review
by: Saeid Safari, et al.
Published: (2020-08-01)

Propolis, Bee Honey, and Their Components Protect against Coronavirus Disease 2019 (COVID-19): A Review of In Silico, In Vitro, and Clinical Studies
by: Amira Mohammed Ali, et al.
Published: (2021-02-01)

Coronavirus Disease 2019 (COVID–19): A Short Review on Hematological Manifestations
by: Artur Słomka, et al.
Published: (2020-06-01)

A case of novel coronavirus (COVID-19)-induced viral myocarditis mimicking a Takotsubo cardiomyopathy
by: Yaser Khalid, DO, et al.
Published: (2020-08-01)

The use of mesenchymal stromal cells in the treatment of coronavirus disease 2019
by: Maurice A. Canham, et al.
Published: (2020-09-01)

Role of Methylprednisolone for Covid-19 Patients Admitted to a Tertiary Care Hospital
by: Komal Arshad, et al.
Published: (2022-12-01)

Paradigm of immune dysregulation in coronavirus disease-2019 infection
by: Om Saswat Sahoo, et al.
Published: (2024-01-01)

COVID-19 and Cytokine Storm
by: Mustafa Kurtuluş, et al.
Published: (2020-12-01)

Coronavirus disease (COVID-19): observations and lessons from primary medical care at a German community hospital
by: Martin Schiller, et al.
Published: (2020-03-01)

CORONAVIRUS DISEASE 2019 (COVID-19): A RHEUMATOLOGIST’S THOUGHTS
by: E. L. Nasonov
Published: (2020-04-01)

Immunopathogenesis of severe acute respiratory syndrome coronavirus-2: evolving knowledge and its current status
by: Nitin Saksena, et al.
Published: (2021-06-01)

A vicious circle between oxidative stress and cytokine storm in acute respiratory distress syndrome pathogenesis at COVID-19 infection
by: G. H. Meftahi, et al.
Published: (2021-02-01)

The novel immunomodulatory biologic LMWF5A for pharmacological attenuation of the “cytokine storm” in COVID-19 patients: a hypothesis
by: Gregory Thomas, et al.
Published: (2020-05-01)

Coronavirus disease 2019 in a patient with pulmonary fibrosis and emphysema: An autopsy report
by: Risa Kudo, et al.
Published: (2023-11-01)

COVID-19: Immunopathogenesis
by: Deniz MAVİ, et al.
Published: (2020-06-01)

Respiratory epithelium: Place of entry and / or defense against SARS-CoV-2 virus
by: Leštarević Snežana, et al.
Published: (2021-01-01)

Interleukin-8 as a Biomarker for Disease Prognosis of Coronavirus Disease-2019 Patients
by: Lili Li, et al.
Published: (2021-01-01)

Immunomodulatory and Antiviral Activity of Metformin and Its Potential Implications in Treating Coronavirus Disease 2019 and Lung Injury
by: Xianyang Chen, et al.
Published: (2020-08-01)

Clinical value of immune-inflammatory parameters to assess the severity of coronavirus disease 2019
by: Zhe Zhu, et al.
Published: (2020-06-01)

IMMUNOPATHOLOGY AND IMMUNOPHARMACOTHERAPY OF CORONAVIRUS DISEASE 2019 (COVID-19): FOCUS ON INTERLEUKIN 6
by: E. L. Nasonov
Published: (2020-06-01)

A Closer Look at Dexamethasone and the SARS-CoV-2-Induced Cytokine Storm: In Silico Insights of the First Life-Saving COVID-19 Drug
by: Paul Morgan, et al.
Published: (2021-12-01)

Tocilizumab and COVID-19: Timing of Administration and Efficacy
by: Emna Abidi, et al.
Published: (2022-02-01)

Hemoperfusion Therapy’s Efficiency in Reducing Serum IL-6 Levels and Disease Severity in COVID-19 Patients
by: Mohammad Bakhshivand, et al.
Published: (2022-12-01)

Anti-CD6 humanized monoclonal antibody itolizumab, halts disease progression and severity of acute respiratory distress syndrome in COVID-19 disease: A case study
by: Hemant P Thacker, et al.
Published: (2021-01-01)

Dysregulated immune response in SARS-CoV-2 infections
by: Marilaeta Cindryani, et al.
Published: (2020-01-01)

Anakinra authorized to treat severe coronavirus disease 2019; Sepsis breakthrough or time to reflect?
by: Leland Shapiro, et al.
Published: (2023-10-01)

Severe Acute Respiratory Syndrome Coronavirus-2 Induces Cytokine Storm and Inflammation During Coronavirus Disease 19: Perspectives and Possible Therapeutic Approaches
by: Federica Mannino, et al.
Published: (2020-11-01)

Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths
by: William B. Grant, et al.
Published: (2020-04-01)

Δ9-Tetrahydrocannabinol Prevents Mortality from Acute Respiratory Distress Syndrome through the Induction of Apoptosis in Immune Cells, Leading to Cytokine Storm Suppression
by: Amira Mohammed, et al.
Published: (2020-08-01)

COVID 19 and diabetes: An endocrinologist's perspective
by: Kishore K Behera, et al.
Published: (2020-01-01)

COVID-19/SARS-CoV-2 Infection: Lysosomes and Lysosomotropism Implicate New Treatment Strategies and Personal Risks
by: Markus Blaess, et al.
Published: (2020-07-01)

Repurposing existing medications for coronavirus disease 2019: protocol for a rapid and living systematic review
by: Benjamin P. Geisler, et al.
Published: (2021-05-01)